Posted on

Pfizer has started clinical trials of a pill Covid-19 patients can take as soon as they start developing symptoms

Pfizer Logo

the staff of the Ridgewood blog

Ridgewood NJ, Pfizer has started stage one clinical trials on an oral pill designed to be an early intervention for Covid-19. The pill has demonstrated potent in-vitro antiviral activity against SARS-CoV-2. It can be used with other antivirals to create a treatment that complements vaccination. The pill is a protease inhibitor. It binds to a viral enzyme to prevent the virus from replicating in the cell. More information about the clinical trials will be shared on April 6.

The company claims Covid-19 patients can take as soon as they start developing symptoms. If the trail is successful, this could be the first early intervention for Covid of its kind that could prevent the worsening of symptoms.

Pfizer is conducting the trial in the US for now and says that it has so far “demonstrated potent in-vitro antiviral activity” against the virus that causes Covid-19, “as well as activity against other coronaviruses, suggesting potential for use in the treatment of Covid-19 as well as potential use to address future coronavirus threats”.

Pfizer chief scientific officer Mikael Dolsten was quoted by media as saying: “Together, the two [oral and intravenous antivirals] have the potential to create an end to end treatment paradigm that complements vaccination.”

 

Leave a Reply

Your email address will not be published. Required fields are marked *